Clinical Scorecard: Trends in Influenza Vaccination Rates for Children and Adolescents from 2017 to 2023
At a Glance
Category
Detail
Condition
Influenza and influenza vaccination
Key Mechanisms
Vaccination coverage among children and adolescents varies by age and insurance type.
Target Population
Children and adolescents aged 2 months to 18 years attending Montefiore Medical Group clinics
Care Setting
Montefiore Medical Group clinics; school-based health centers are noted as an alternative vaccination site.
Key Highlights
Influenza vaccination coverage among children and adolescents attending Montefiore Medical Group clinics varied from 2017 to 2023.
Coverage differed by age and insurance type.
Primary care physicians can help improve vaccination uptake by strongly recommending vaccination and expanding access through alternative sites.
Guideline-Based Recommendations
Diagnosis
Assess influenza vaccination status during clinical visits for children and adolescents.
Management
Encourage primary care physicians to strongly recommend influenza vaccination.
Expand access to vaccination through alternative sites such as school-based health centers.
Monitoring & Follow-up
Monitor vaccination coverage over time and assess differences by age and insurance type.
Follow up with patients who are not up to date on influenza vaccination and offer vaccination when appropriate.
Risks
Children and adolescents who are not vaccinated may remain susceptible to influenza.
Differences in coverage by age and insurance type may indicate disparities in access or uptake.
Patient & Prescribing Data
Children and adolescents aged 2 months to 18 years attending Montefiore Medical Group clinics.
Vaccination coverage is influenced by age and insurance type.
Clinical Best Practices
Review and document influenza vaccination status during routine care.
Strongly recommend vaccination and provide opportunities to receive it in primary care or at accessible alternative sites, such as school-based health centers.
Use coverage trends by age and insurance type to identify groups that may benefit from additional outreach.
Open Forum Infectious Diseases, Open Forum Infectious Diseases, 2025 -- A Classification System for Analyzing Trends in Influenza-Related Hospital Admissions in the United States
The Journal of Infectious Diseases, The Journal of Infectious Diseases, 2025 -- A Potential Platform for Future Vaccine Trials Identifies a High Incidence of Symptomatic and Asymptomatic Influenza Infection Among Children Aged 6 to 23 Months in South Africa
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices -- United States, 2025–26 Influenza Season | MMWR
The Journal of Infectious Diseases — Influenza Vaccine-Averted Illness in Chile, Guyana, and Paraguay During 2013–2018: A Standardized Approach to Assess the Value of Vaccination
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2025–26 Influenza Season | MMWR
Interim Estimates of 2025–26 Seasonal Influenza Vaccine Effectiveness —
Full article: Real-world effectiveness of live attenuated influenza vaccines (LAIV) and inactivated influenza vaccines (IIV) in children from 2003 to 2023: a systematic literature review and network meta-analysis
Investigators linked distinct odor patterns to life stage, sex, and skin microbes, while limited longitudinal evidence leaves their clinical utility uncertain.
